Malaria vaccine (MSP3-LSP) - Vac4All

Drug Profile

Malaria vaccine (MSP3-LSP) - Vac4All

Alternative Names: MSP3-LSP aduvanted in Aluminium Hydroxide (AIOH) - Vac4All; MSP3-LSP/AIOH malaria vaccine - Vac4All

Latest Information Update: 09 Feb 2016

Price : $50

At a glance

  • Originator Vac4All
  • Class Antimalarials; Parasitic vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Falciparum malaria

Most Recent Events

  • 01 May 2011 Phase-II clinical trials in Falciparum malaria (Prevention, In children) in Mali (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top